Spruce Biosciences, Inc.
General ticker "SPRB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.9M (TTM average)
Spruce Biosciences, Inc. follows the US Stock Market performance with the rate: 33.7%.
Estimated limits based on current volatility of 3.6%: low 66.69$, high 71.71$
Factors to consider:
- Total employees count: 29 (+7.4%) as of 2023
- Top business risk factors: Limited operating history, Speculative nature of biopharma investments, Economic downturns and volatility, Market competition, Liquidity and credit risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [27.88$, 90.22$]
- 2026-12-31 to 2027-12-31 estimated range: [12.14$, 44.05$]
Short-term SPRB quotes
Long-term SPRB plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $36.51MM |
| Operating Income | $-36.51MM |
| Non-Operating Income | $-2.45MM |
| Interest Expense | $0.09MM |
| R&D Expense | $19.52MM |
| Income(Loss) | $-38.97MM |
| Profit(Loss)* | $-38.97MM |
| Stockholders Equity | $42.52MM |
| Assets | $53.02MM |
| Operating Cash Flow | $-33.33MM |
| Financing Cash Flow | $43.48MM |
| Earnings Per Share** | $-50.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.